TS-142
Showing 1 - 25 of 540
The Next-day Residual Effects Trial in Tokyo (TS-142, Zopiclone, Placebo)
Not yet recruiting
- The Next-day Residual Effects
- TS-142
- +2 more
-
Tokyo, JapanTaisho Pharmaceutical Co., Ltd selected site
Apr 6, 2023
Effect of Food Trial in Tokyo (TS-142 10 mg)
Not yet recruiting
- Effect of Food
- TS-142 10 mg
-
Tokyo, JapanTaisho Pharmaceutical Co., Ltd selected site
Jan 22, 2023
Patients With Mild or Moderate Hepatic Impairment Trial in Tokyo (TS-142 5 mg)
Recruiting
- Patients With Mild or Moderate Hepatic Impairment
- TS-142 5 mg
-
Tokyo, JapanTaisho Pharmaceutical Co., Ltd selected site
Dec 27, 2022
Healthy Volunteer Trial in Sumida-ku (Step 1: TS-142, Step 2: TS-142, Step 2: Placebo)
Completed
- Healthy Volunteer
- Step 1: TS-142
- +2 more
-
Sumida-ku, Tokyo, JapanSumida Hospital
Oct 4, 2022
Healthy Male Subjects Trial in Tokyo ([14C] TS-142)
Completed
- Healthy Male Subjects
- [14C] TS-142
-
Tokyo, JapanTaisho Pharmaceutical Co., Ltd selected site
Oct 5, 2022
Healthy Subjects Trial in Toshima-ku (TS-142, Moxifloxacin, Placebo)
Completed
- Healthy Subjects
- TS-142
- +2 more
-
Toshima-ku, JapanTaisho Pharmaceutical Co., Ltd selected site
Oct 5, 2022
Insomnia Disorder Trial in Tokyo (TS-142, Dose-matched Placebo to TS-142)
Completed
- Insomnia Disorder
- TS-142
- Dose-matched Placebo to TS-142
-
Tokyo, JapanTaisho Pharmaceutical Co., Ltd selected site
Oct 4, 2022
Healthy Subjects Trial in Tokyo (TS-142, Itraconazole)
Completed
- Healthy Subjects
- TS-142
- Itraconazole
-
Tokyo, JapanTaisho Pharmaceutical Co., Ltd selected site
Oct 4, 2022
Patients With Insomnia Trial in Tokyo (TS-142 5 mg, TS-142 10 mg, Placebo to TS-142)
Not yet recruiting
- Patients With Insomnia
- TS-142 5 mg
- +2 more
-
Tokyo, JapanTaisho Pharmaceutical Co., Ltd selected site
Aug 16, 2022
Patients With Insomnia Trial in Tokyo (TS-142 5 mg, TS-142 10 mg)
Not yet recruiting
- Patients With Insomnia
- TS-142 5 mg
- TS-142 10 mg
-
Tokyo, JapanTaisho Pharmaceutical Co., Ltd selected site
Aug 16, 2022
Healthy Subjects Trial in Tokyo (TS-142, Zopiclone, Placebo)
Completed
- Healthy Subjects
- TS-142
- +2 more
-
Tokyo, JapanTaisho Pharmaceutical Co., Ltd selected site
Jan 12, 2022
Patients With Mild Obstructive Sleep Apnea Hypopnea Trial in Tokyo (TS-142, Dose-matched Placebo to TS-142)
Completed
- Patients With Mild Obstructive Sleep Apnea Hypopnea
- TS-142
- Dose-matched Placebo to TS-142
-
Tokyo, JapanTaisho Pharmaceutical Co., Ltd selected site
Nov 21, 2021
Patients With Insomnia Trial in Tokyo (TS-142)
Completed
- Patients With Insomnia
- TS-142
-
Tokyo, JapanTaisho Pharmaceutical Co., Ltd selected site
Dec 13, 2021
Healthy Volunteers Trial in Austin (TS-142, TS-142 Placebo)
Completed
- Healthy Volunteers
- TS-142
- TS-142 Placebo
-
Austin, TexasPPD Phase I unit
Feb 5, 2021
Healthy Volunteer Trial in Fukuoka (Placebo (fasting), Placebo (feeding), 1 mg of TS-142)
Completed
- Healthy Volunteer
- Placebo (fasting)
- +6 more
-
Fukuoka, JapanThe medical facility selected by Taisho Pharmaceutical Co., Ltd
Nov 19, 2019
Healthy Volunteer Trial in Fukuoka (Placebo, TS-142, 10 mg, TS-142, 20 mg)
Completed
- Healthy Volunteer
- Placebo
- +3 more
-
Fukuoka, JapanThe medical facility selected by Taisho Pharmaceutical Co., Ltd
Nov 19, 2019
Urinary Exosome in Type 2 Diabetic Nephropathy and Evaluation of
Active, not recruiting
- Diabetic Nephropathy
- Grouping based on previous laboratory results, no intervention.
-
Jinan, Shandong, ChinaQianfoshan Hospital
Oct 24, 2023
Immunotherapy in Advanced or Locally Advanced dMMR/MSI-H
Recruiting
- Colorectal Cancer
-
Shanghai, ChinaFudan University Shanghai Cancer Center
Oct 18, 2023
Fertility Attitudes of Adolescents and Young Turner Syndrome and
Recruiting
- Fertility Perservation
- Fertility
-
Bethesda, MarylandNational Institute of Child Health and Human Development (NICHD)
Feb 2, 2023
Multiple Sclerosis, Transcranial Direct Current Stimulation Trial in Istanbul (Transcutaneous Spinal Direct Current Stimulation)
Recruiting
- Multiple Sclerosis
- Transcranial Direct Current Stimulation
- Transcutaneous Spinal Direct Current Stimulation
-
Istanbul, Kadıköy, TurkeyCadde Tıp Merkezi
Oct 31, 2023
Biliary Tract Cancer Trial in Kaohsiung, Taichung (D07001-softgel capsules + Xeloda (or TS-1), mFOLFOX)
Recruiting
- Biliary Tract Cancer
- D07001-softgel capsules + Xeloda (or TS-1)
- mFOLFOX
-
Kaohsiung, Taiwan
- +4 more
Dec 22, 2022
Post-Intubation Tracheal Stenosis and Covid-19
Recruiting
- Tracheal Stenosis
- +3 more
- tracheal stenosis follow-up file
-
Çankaya, Ankara, TurkeyAnkara City Hospital
Jan 11, 2023
GERD, Hiatal Hernia Trial in United States (LAPAROSCOPIC PARAESOPHAGEAL HIATAL HERNIA REPAIR COMBINED WITH TRANSORAL
Recruiting
- GERD
- Hiatal Hernia
- LAPAROSCOPIC PARAESOPHAGEAL HIATAL HERNIA REPAIR COMBINED WITH TRANSORAL INCISIONLESS FUNDOPLICATION
-
Irvine, California
- +6 more
Jan 31, 2023
Hyperphosphatemia Patients on Hemodialysis Trial in Tokyo (TS-172 10mg bid, TS-172 30mg bid, TS-172 60mg bid)
Not yet recruiting
- Hyperphosphatemia Patients on Hemodialysis
- TS-172 10mg bid
- +4 more
-
Tokyo, JapanTaisho Pharmaceutical Co., Ltd selected site
Jan 23, 2023
Dental Implant, Dental Implant-Abutment Design Trial in Sassari (Implant placement)
Not yet recruiting
- Dental Implant
- Dental Implant-Abutment Design
- Implant placement
-
Sassari, ItalyMarco Tallarico
Apr 24, 2023